Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Tendyne Holdings

Explore full profile

Medical device company developing a transcatheter aortic valve implantation system

Rockville, United StatesFounded 2010Biotech & Life Sciences
Valuation $250–500M Last recorded · 2015
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Tendyne Holdings and the history behind them.

About Tendyne Holdings

Tendyne is a pioneering company in the field of structural heart therapies, specializing in transcatheter mitral valve repair technology. The company operates in the medical device market, primarily serving healthcare providers and patients suffering from mitral regurgitation, a condition where the heart's mitral valve doesn't close tightly, allowing blood to flow backward in the heart. Tendyne's core product, the Tendyne Transcatheter Mitral Valve Implantation (TMVI), offers a minimally invasive solution for patients who are at high surgical risk. This product is designed to improve patient outcomes by providing a less invasive alternative to traditional open-heart surgery. The business model revolves around the development, manufacturing, and distribution of these advanced medical devices, generating revenue through direct sales to hospitals and healthcare facilities. Tendyne's market is global, with a focus on regions where there is a high prevalence of mitral regurgitation and a growing demand for innovative heart therapies. The company leverages clinical data and ongoing trials to continuously improve its products and expand its market reach.

Source: Dealroom company data

At a glance

Status
Acquired
Founded
2010
Headquarters
Rockville, United States
Employees
4
Open positions
None listed
Dealroom signal
24.7/100
Industry
Health
Sub-industry
BioTechnology, Medical Devices
Sector
Biotech & Life Sciences, Biotechnology, Cardiology and cardiovascular, Spinout, Biotech and Pharma, DT and LS, science-based
Client focus
b2b

Funding history

4 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
ACQUISITION✓Exit Jul 2015 $250M $250M Abbott —
SERIES C✓Equity / VC Apr 2014 $25M $100M Apple Tree Partners —
Showing the latest 2 of 4 recorded eventsBook a demo for the full funding history →

Growth signals

Tendyne Holdings website traffic

Latest recorded traffic for Tendyne Holdings is 0 monthly website visits. Tendyne Holdings's team declined 50% over the past year.

Latest monthly visits0 1-year team growth-50%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

3 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later1 investor entered at this stage

  • Apple Tree Partners

Other known investors2 additional known investors

  • Abbott
  • Colorado State University
Team profiled 5 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Tendyne Holdings on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Tendyne Holdings’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.